Medtronic has outlined both its current market position and ambitious future at the ongoing J.P. Morgan Healthcare Conference. During its presentation, Medtronic stated that several of the key markets it targets, including pulsed-field ablation (PFA) and renal denervation, have the potential to become multi-billion-dollar opportunities in the near future. Following years of investing, Medtronic is now ready to focus on growth. According to GlobalData’s US Healthcare Facility Invoicing Database, Medtronic ...